Skip to main content
SpringerLink
Log in

Does the use of doxazosin influence the success of SWL in the treatment of upper ureteral stones? A multicenter, prospective and randomized study

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

The objective of the study is to investigate the effect of doxazosin, administered to the subjects who underwent SWL due to upper ureteral stones, on therapeutic outcomes. The study enrolled the patients with a radio-opaque stone ≥5 mm in upper ureter. Patients were randomized into two groups: the first group underwent SWL following the diagnosis and they were recommended to receive oral hydration. The second group underwent SWL after initiating alpha blocker (doxazosin controlled-release tablet 4 mg/day) and drug therapy was continued until that the patient has been stone free. Parameters of SWL procedure, Steinstrasse, pain score at admission, time to stone passage, the complications developed, the additional procedures that were administered and number of hospital visits done due to pain during the treatment were recorded. A total of 79 patients were enrolled to the study. The subjects evaluated included 35 patients, who received an alpha blocker and 44 patients who did not receive an alpha blocker. For both groups, the level of energy applied per SWL session, the diameter of the stone, the number of hospital visits done due to pain, pain score and the need for analgesia were found to be similar (p > 0.05). The group of doxazosin was more advantageous in terms of stone-free rate, the need for additional procedures and Steinstrasse (p < 0.05). In conclusion, the addition of doxazosin to SWL therapy administered for upper ureteral stones reduces Steinstrasse, and thereby, the need for additional procedures and increases post-treatment stone-free rate. A positive effect of doxazosin on the time to stone passage was not shown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ramello A, Vitale C, Marangella M (2000) Epidemiology of nephrolithiasis. J Nephrol 13(Suppl 3):45–50

    Google Scholar 

  2. Chaussy C, Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V (1982) First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol 127:417–420

    PubMed  CAS  Google Scholar 

  3. Preminger GM, Tiselius HG, Assimos DG et al (2007) 2007 Guideline for the management of ureteral calculi. Eur Urol 52:1610–1631

    Article  PubMed  Google Scholar 

  4. Kim FJ, Rice KR (2006) Prediction of shockwave failure in patients with urinary tract stones. Curr Opin Urol 16:88–92

    Article  PubMed  Google Scholar 

  5. Argyropoulos AN, Tolley DA (2007) Optimizing shock wave lithotripsy in the 21st century. Eur Urol 52:344–352

    Article  PubMed  Google Scholar 

  6. Hochreiter WW, Danuser H, Perrig M, Studer UE (2003) Extracorporeal shock wave lithotripsy for distal ureteral calculi: what a powerful machine can achieve. J Urol 169:878–880

    Article  PubMed  Google Scholar 

  7. Bouffioux CR, Penders L (1984) Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem. Eur Urol 10:306–310

    PubMed  CAS  Google Scholar 

  8. Hollingsworth JM, Rogers MA, Kaufman SR et al (2006) Medical therapy to facilitate urinary stone passage: a metaanalysis. Lancet 368:1171–1179

    Article  PubMed  Google Scholar 

  9. Sterrett SP, Nakada SY (2008) Medical expulsive therapy. Curr Opin Urol 18:210–213

    Article  PubMed  Google Scholar 

  10. Michel MC, de la Rosette JJ (2006) Alphablocker treatment of urolithiasis. Eur Urol 50:213–214

    Article  PubMed  Google Scholar 

  11. Menon M, Resnick MI (2002) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC (ed) Campbell’s urology. Saunders, Philadelphia, pp 3227–3229

    Google Scholar 

  12. Stoller ML, Bolton DM (2000) Urinary stone disease. In: Tanagho EA (ed) Smith’s urology. Lange Medical Book/McGraw-Hill, San Francisco, pp 292–320

    Google Scholar 

  13. Miyatake R, Tomiyama Y, Murakami M et al (2001) Effects of isoproterenol and butylscopolamine on the friction between an artificial stone and the intraureteral wall in anesthetized rabbits. J Urol 166:1083–1087

    Article  PubMed  CAS  Google Scholar 

  14. Weiss RM (2002) Physiology and pharmacology of renal pelvis and ureter. In: Walsh PC (ed) Campbell’s urology. Saunders, Philadelphia, pp 377–456

    Google Scholar 

  15. Sivula A, Lehtonen T (1967) Spontaneous passage of artificial concretions applied in the rabbit ureter. Scand J Urol Nephrol 1:259–263

    Article  PubMed  CAS  Google Scholar 

  16. Tiselius HG, Aronsen T, Bohgard S et al (2010) Is high diuresis an important prerequisite for successful SWL-disintegration of ureteral stones? Urol Res 38:143–146

    Article  PubMed  Google Scholar 

  17. Hancock AA (1996) α1 Adrenoceptor: a synopsis of their pharmacology and molecular biology. Drug Dev Res 39:54–107

    Article  CAS  Google Scholar 

  18. Sigala S, Dellabella M, Milanese G et al (2004) Alpha1 adrenoceptor subtypes in men juxtavesical ureter: molecular and pharmacological characterization. Eur Urol 3(Suppl):119–122

    Google Scholar 

  19. Hieble JP, Caine M, Zalaznik E (1985) In vitro characterization of the alpha-adrenoceptors in human prostate. Eur J Pharmacol 107:111–117

    Article  PubMed  CAS  Google Scholar 

  20. Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202–2205

    Article  PubMed  CAS  Google Scholar 

  21. Porpiglia F, Ghignone G, Fiori C et al (2004) Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172:568–571

    Article  PubMed  CAS  Google Scholar 

  22. Wang Huijun, Liu Ke, Ji Zhigang, Li Hanzhong (2010) Effect of α1-adrenergic antagonists on lower ureteral stones with extracorporeal shock wave lithotripsy. Asian J Surg 33(1):37–41

    Article  PubMed  CAS  Google Scholar 

  23. Sigala S, Dellabella M, Milanese G et al (2005) Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24:142–148

    Article  PubMed  CAS  Google Scholar 

  24. Liatsikos EN, Katsakiori PF, Assimakopoulos K, Voudoukis T, Kallidonis P, Constantinides C, Athanasopoulos A, Stolzenburg JU, Perimenis P (2007) Doxazosin for the management of distal-ureteral stones. J Endourol 21(5):538–541

    Article  PubMed  CAS  Google Scholar 

  25. Autorino R, De Sio M, Damiano R, Di Lorenzo G, Perdonà S, Russo A, Quarto G, Cosentino L, D’Armiento M (2005) The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand? Urol Res 33(6):460–464

    Article  PubMed  Google Scholar 

  26. Hermanns T, Sauermann P, Rufibach K, Frauenfelder T, Sulser T, Strebel RT (2009) Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol 56(3):407–412

    Article  PubMed  Google Scholar 

  27. Zhu Y, Duijvesz D, Rovers MM, Lock TM (2009) Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int 106(2):256–261

    Article  PubMed  Google Scholar 

  28. Kobayashi M, Naya Y, Kino M et al (2008) Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 15:495–498

    Article  PubMed  CAS  Google Scholar 

  29. Zehri AA, Ather MH, Abbas F, Biyabani SR (2010) Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology 75(6):1285–1288

    Article  PubMed  Google Scholar 

  30. Ayubov B, Arustamov D, Mukhtarov S (2007) Efficacy of doxazosin in the management of ureteral stones. Eur Urol Suppl 6:114 (abstract 368)

    Article  Google Scholar 

  31. Liatsikos EN, Katsakiori PF, Assimakopoulos K et al (2007) Doxazosin for the management of distal-ureteral stones. J Endourol 21:538–541

    Article  PubMed  CAS  Google Scholar 

  32. Mukhtarov S, Turdiev A, Fozilov A et al (2007) Using doxazosin for distal ureteral stone clearance with or without shock wave lithotripsy. Eur Urol Suppl 6:216 (abstract 774)

    Article  Google Scholar 

  33. Ukhal MI, Malomuzh OI, Strashny V (1999) Administration of doxazosin for speedy elimination of stones from lower section of ureter. Eur Urol 35(Suppl 2):4–6

    Google Scholar 

  34. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different a1-adrenergic blocker for distal ureteral stones. J Urol 173:2010–2012

    Article  PubMed  CAS  Google Scholar 

  35. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56:455–471

    Article  PubMed  Google Scholar 

  36. Shaaban AM, Barsoum NM, Sagheer GA, Ahmed Z (2008) Is there a role for alpha blockers after SWL for renal and upper ureteral stones? J Urol 179:A1459

    Article  Google Scholar 

  37. Lee SH, Park KK, Mah SY, Chung BH (2010) Effects of alpha blocker add on treatment on blood pressure in symptomatic BPH with or without concomitant hypertension. Prostate Cancer Prostatic Dis 13:333–337

    Article  PubMed  CAS  Google Scholar 

  38. Kirby RS, Andersen M, Gratzke P, Dahlstrand C, Hoye K (2001) A combined analysis of double blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. BJU Int 87:192–200

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, GATA Haydarpasa Teaching Hospital, 34668, Uskudar, Istanbul, Turkey

    Ferhat Ateş & Temuçin Şenkul

  2. 1st Urology Clinic, Dr. Lütfi Kırdar Kartal Teaching and Research Hospital, Istanbul, Turkey

    Bilal Eryıldırım

  3. 2nd Urology Clinic, Haydarpasa Numune Teaching and Research Hospital, Istanbul, Turkey

    Metin Ishak Öztürk

  4. Urology Clinic, Umraniye Teaching and Research Hospital, Istanbul, Turkey

    Turgay Turan & Mete Oğuz Ekinci

  5. 2nd Urology Clinic, Göztepe Teaching and Research Hospital, Istanbul, Turkey

    Cenk Gürbüz

  6. 1st Urology Clinic, Göztepe Teaching and Research Hospital, Istanbul, Turkey

    Asıf Yıldırım

  7. 2nd Urology Clinic, Dr. Lütfi Kırdar Kartal Teaching and Research Hospital, Istanbul, Turkey

    Cemal Göktaş

  8. Department of Urology, School of Medicine, Yeditepe University, Istanbul, Turkey

    Kemal Sarıca

Authors
  1. Ferhat Ateş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bilal Eryıldırım
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Metin Ishak Öztürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Turgay Turan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cenk Gürbüz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mete Oğuz Ekinci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Asıf Yıldırım
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Cemal Göktaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Temuçin Şenkul
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kemal Sarıca
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

AYTAG group

Corresponding author

Correspondence to Ferhat Ateş.

Additional information

All authors are the members of AYTAG group. AYTAG group is Anatolian region of Istanbul, Stone Research Group (Anadolu Yakası Taş Araştırma Grubu).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ateş, F., Eryıldırım, B., Öztürk, M.I. et al. Does the use of doxazosin influence the success of SWL in the treatment of upper ureteral stones? A multicenter, prospective and randomized study. Urol Res 40, 537–542 (2012). https://doi.org/10.1007/s00240-011-0455-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-011-0455-x

Keywords

Search

Navigation